MedPath

STARLIX 60MG

STARLIX 60MG

Discontinued
DIN Number

02245438

Drug Class

Human

Market Date

Mar 5, 2002

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02245438
AIG Number0146561001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BX03 NATEGLINIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

NATEGLINIDEActive
Strength: 60 MG
Monograph: NATEGLINIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.